Bradley Burnam
Vermogen: 115 M $ op 30-06-2026
Vermogen: 115 M $ op 30-06-2026
Bradley Burnam is the founder of Turn Therapeutics, Inc., founded in 2015, holding the title of Chairman & Chief Executive Officer.
Mr. Burnam is also the founder of Turn Therapeutics (TM), Inc...
Mr. Burnam currently holds the position of Director at Baropace, Inc., starting in 2020.
Education history includes graduate studies at Stanford University and undergraduate studies at the University of California, Los Angeles.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TURN THERAPEUTICS INC. 52,76% | 28-05-2026 | 15.716.260 ( 52,76% ) | 115 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TURN THERAPEUTICS INC. | Algemeen Directeur | 06-01-2015 |
Turn Therapeutics(TM), Inc
Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Algemeen Directeur | 01-01-2015 |
Baropace, Inc.
Baropace, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable devices intended for cardiac health monitoring | Directeur/Bestuurslid | 01-12-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baropace, Inc.
Baropace, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops wearable devices intended for cardiac health monitoring | Electronic Technology |
Turn Therapeutics(TM), Inc
Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Health Technology |
Global Health Solutions Inc
Global Health Solutions Inc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and medical device development company that provides solutions for dermatological diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau